194 related articles for article (PubMed ID: 2572588)
1. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.
Mickley LA; Bates SE; Richert ND; Currier S; Tanaka S; Foss F; Rosen N; Fojo AT
J Biol Chem; 1989 Oct; 264(30):18031-40. PubMed ID: 2572588
[TBL] [Abstract][Full Text] [Related]
2. Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate.
Bates SE; Currier SJ; Alvarez M; Fojo AT
Biochemistry; 1992 Jul; 31(28):6366-72. PubMed ID: 1352990
[TBL] [Abstract][Full Text] [Related]
3. Variable effects of sodium butyrate on the expression and function of the MDR1 (P-glycoprotein) gene in colon carcinoma cell lines.
Frommel TO; Coon JS; Tsuruo T; Roninson IB
Int J Cancer; 1993 Sep; 55(2):297-302. PubMed ID: 8103760
[TBL] [Abstract][Full Text] [Related]
4. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.
Bates SE; Mickley LA; Chen YN; Richert N; Rudick J; Biedler JL; Fojo AT
Mol Cell Biol; 1989 Oct; 9(10):4337-44. PubMed ID: 2573830
[TBL] [Abstract][Full Text] [Related]
5. Modulation of mdr-1 expression by a H-ras oncogene in a human colon carcinoma cell line.
Kramer R; Weber TK; Arceci R; Morse B; Simpson H; Steele GD; Summerhayes IC
Int J Cancer; 1993 May; 54(2):275-81. PubMed ID: 8098015
[TBL] [Abstract][Full Text] [Related]
6. Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.
Herzog CE; Tsokos M; Bates SE; Fojo AT
J Biol Chem; 1993 Feb; 268(4):2946-52. PubMed ID: 8094079
[TBL] [Abstract][Full Text] [Related]
7. Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.
Shibata H; Kanamaru R; Sato T; Ishioka C; Konishi Y; Ishikawa A; Wakui A; Tsuruo T
Jpn J Cancer Res; 1990 Dec; 81(12):1214-7. PubMed ID: 1980493
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.
Lai GM; Chen YN; Mickley LA; Fojo AT; Bates SE
Int J Cancer; 1991 Nov; 49(5):696-703. PubMed ID: 1682280
[TBL] [Abstract][Full Text] [Related]
9. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.
Herzog CE; Trepel JB; Mickley LA; Bates SE; Fojo AT
J Natl Cancer Inst; 1992 May; 84(9):711-6. PubMed ID: 1349044
[TBL] [Abstract][Full Text] [Related]
10. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
11. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.
Dong Z; Radinsky R; Fan D; Tsan R; Bucana CD; Wilmanns C; Fidler IJ
J Natl Cancer Inst; 1994 Jun; 86(12):913-20. PubMed ID: 7910854
[TBL] [Abstract][Full Text] [Related]
12. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.
Murphy LD; Herzog CE; Rudick JB; Fojo AT; Bates SE
Biochemistry; 1990 Nov; 29(45):10351-6. PubMed ID: 1979752
[TBL] [Abstract][Full Text] [Related]
13. Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
Bates SE; Shieh CY; Mickley LA; Dichek HL; Gazdar A; Loriaux DL; Fojo AT
J Clin Endocrinol Metab; 1991 Jul; 73(1):18-29. PubMed ID: 1675220
[TBL] [Abstract][Full Text] [Related]
14. Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines.
Murphy LD; Valverius EM; Tsokos M; Mickley LA; Rosen N; Bates SE
Cancer Commun; 1990; 2(10):345-55. PubMed ID: 2206777
[TBL] [Abstract][Full Text] [Related]
15. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines.
Muller C; Bailly JD; Goubin F; Laredo J; Jaffrézou JP; Bordier C; Laurent G
Int J Cancer; 1994 Mar; 56(5):749-54. PubMed ID: 7906257
[TBL] [Abstract][Full Text] [Related]
16. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Ho SB; Yan PS; Dahiya R; Neuschwander-Tetri BA; Basbaum C; Kim YS
J Cell Physiol; 1994 Aug; 160(2):213-26. PubMed ID: 7913708
[TBL] [Abstract][Full Text] [Related]
17. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
18. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
Critchfield JW; Welsh CJ; Phang JM; Yeh GC
Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells.
Kitazono M; Sumizawa T; Takebayashi Y; Chen ZS; Furukawa T; Nagayama S; Tani A; Takao S; Aikou T; Akiyama S
J Natl Cancer Inst; 1999 Oct; 91(19):1647-53. PubMed ID: 10511592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
